FDA Approves Ixekizumab for Treating Active Ankylosing Spondylitis
Ixekizumab vs. Adalimumab for PsA: How Do They Compare?
A New Treatment for Axial Spondyloarthritis?
Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus
Rheumatology Drugs at a Glance, Part 2: Psoriasis
Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis
Results of SPIRIT: A Head-to-Head Trial of Ixekizumab vs. Adalimumab in Active PsA
Ixekizumab Improves Outcomes of Ankylosing Spondylitis
